- Home
- RBNE vs ALBT Comparison
RBNE vs ALBT Comparison
Compare RBNE & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBNE
- ALBT
- Stock Information
- Founded
- RBNE 2024
- ALBT 2014
- Country
- RBNE Cyprus
- ALBT United States
- Employees
- RBNE N/A
- ALBT N/A
- Industry
- RBNE Marine Transportation
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RBNE Consumer Discretionary
- ALBT Health Care
- Exchange
- RBNE Nasdaq
- ALBT Nasdaq
- Market Cap
- RBNE 7.3M
- ALBT 7.4M
- IPO Year
- RBNE N/A
- ALBT N/A
- Fundamental
- Price
- RBNE $1.36
- ALBT $2.80
- Analyst Decision
- RBNE
- ALBT
- Analyst Count
- RBNE 0
- ALBT 0
- Target Price
- RBNE N/A
- ALBT N/A
- AVG Volume (30 Days)
- RBNE 4.2M
- ALBT 75.9K
- Earning Date
- RBNE 09-23-2025
- ALBT 11-11-2025
- Dividend Yield
- RBNE N/A
- ALBT N/A
- EPS Growth
- RBNE N/A
- ALBT N/A
- EPS
- RBNE N/A
- ALBT N/A
- Revenue
- RBNE N/A
- ALBT $1,159,091.00
- Revenue This Year
- RBNE N/A
- ALBT N/A
- Revenue Next Year
- RBNE N/A
- ALBT N/A
- P/E Ratio
- RBNE N/A
- ALBT N/A
- Revenue Growth
- RBNE N/A
- ALBT N/A
- 52 Week Low
- RBNE $1.32
- ALBT $1.87
- 52 Week High
- RBNE $20.57
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- RBNE N/A
- ALBT 68.41
- Support Level
- RBNE N/A
- ALBT $2.04
- Resistance Level
- RBNE N/A
- ALBT $2.63
- Average True Range (ATR)
- RBNE 0.00
- ALBT 0.18
- MACD
- RBNE 0.00
- ALBT 0.09
- Stochastic Oscillator
- RBNE 0.00
- ALBT 89.37
About RBNE Robin Energy Ltd. Common Stock
Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.